BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 27356025)

  • 1. Current and emerging treatment of multiple sclerosis.
    Hart FM; Bainbridge J
    Am J Manag Care; 2016 Jun; 22(6 Suppl):s159-70. PubMed ID: 27356025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of multiple sclerosis.
    Perrin Ross A
    Am J Manag Care; 2013 Nov; 19(16 Suppl):s301-6. PubMed ID: 24494619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diagnosis and early treatment on the course of multiple sclerosis.
    Noyes K; Weinstock-Guttman B
    Am J Manag Care; 2013 Nov; 19(17 Suppl):s321-31. PubMed ID: 24494633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview and diagnosis of multiple sclerosis.
    Hunter SF
    Am J Manag Care; 2016 Jun; 22(6 Suppl):s141-50. PubMed ID: 27356023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment optimization in multiple sclerosis.
    Freedman MS; Patry DG; Grand'Maison F; Myles ML; Paty DW; Selchen DH;
    Can J Neurol Sci; 2004 May; 31(2):157-68. PubMed ID: 15198439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
    Happe LE
    Am J Manag Care; 2013 Nov; 19(17 Suppl):s332-42. PubMed ID: 24494634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.
    Berger JR
    Am J Manag Care; 2011 May; 17 Suppl 5 Improving():S146-53. PubMed ID: 21761953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
    Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H
    J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials].
    Ozawa K; Saida T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational clinical immunotherapy for multiple sclerosis.
    Hunter SF; Weinshenker BG; Carter JL; Noseworthy JH
    Mayo Clin Proc; 1997 Aug; 72(8):765-80. PubMed ID: 9276606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis.
    Sternberg Z; Leung C; Sternberg D; Yu J; Hojnacki D
    Cardiovasc Ther; 2014 Apr; 32(2):33-9. PubMed ID: 24119301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis update.
    Markowitz CE
    Am J Manag Care; 2013 Nov; 19(16 Suppl):s294-300. PubMed ID: 24494618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Yes].
    Brochet B
    Rev Neurol (Paris); 2013 Nov; 169(11):858-63. PubMed ID: 24094530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AANA Journal course: update for nurse anesthetists--an overview of multiple sclerosis and implications for anesthesia.
    Schneider KM
    AANA J; 2005 Jun; 73(3):217-24. PubMed ID: 16010775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Sclerosis.
    Yamout BI; Alroughani R
    Semin Neurol; 2018 Apr; 38(2):212-225. PubMed ID: 29791948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No].
    Edan G
    Rev Neurol (Paris); 2013 Nov; 169(11):864-8. PubMed ID: 24125462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.